<DOC>
	<DOC>NCT00939341</DOC>
	<brief_summary>The purpose of this study is to compare whether Symbicort Maintenance &amp; Reliever Therapy (SMART) is more effective in uncontrolled asthmatic patients than their current therapy in a real life situation.</brief_summary>
	<brief_title>Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Provision of signed informed consent Asthma diagnosis at least 6 months before visit 1 of study Patients who have reversible airway obstruction continuous asthma treatment except Symbicort at least within 4 weeks before visit 1 of study Known or suspected allergy to active ingredients of study medication or excipients Use of oral, rectal or parenteral glucocorticosteroids 30 days before visit 1 of study Smoking, current or previous with a smoking history of â‰¥ 10 pack years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Symbicort SMART</keyword>
</DOC>